Impact of HIV Status Notification on Risk Behaviors among Men Who Inject Drugs in Kermanshah, West of Iran

Background: It is unclear whether knowing of current HIV status is associated with change in injecting behaviors among people who inject drugs (PWID) in Iran. The objective of the present study was to determine whether awareness of HIV positive status is associated with a reduction in injecting risk behaviors, after matching for socio-demographic characteristics. Methods: Five hundred male PWID were recruited in 2014 from two drop-in centers (DICs) in Kermanshah west of Iran. Trained interviewers collected data on socio-demographic characteristics, HIV testing and drug-related risk behaviors over the last month prior to interview using a structured questionnaire. Our primary exposure of interest was awareness of HIV status used to group participants into three categories: positive, negative, unaware. We used coarsened exact matching to make the three groups statistically equivalent based on age, place of residence, education and income, and then compared them regarding the proportion of borrowing, lending and reuse of syringes. Results: Matched sample (n=320) had a mean age ± standard deviation (SD) of 33.5 ±7.6 yr. Overall, 25% (95% CI: 14%, 32%) of participants reported "borrowing a syringe" in the past month and 15% (95% CI: 7%, 22%) of them reported "lending a used syringe" to others in the past month. In comparison to PWID who were unaware of their HIV status, those knew they were HIV positive (OR 1.68, CI95%1.32–2.81) or negative (OR 1.54; 95% CI: 1.28, 2.71) were both more likely to report borrowing syringes in past month. Conclusions: PWID WHO know they are positive for HIV are more likely to borrow another person’s syringe, to report reuse of their own used syringes and less likely to report lending their syringes to others. Strategies to scale up HIV testing and counseling for PWID, which also increase awareness of HIV status, may decrease injecting related the risk behaviors.

[1]  M. Noroozi,et al.  Comparing profile of people who inject drugs (PWID) accessing different types of needle and syringe programs or secondary distribution in Kermanshah, Iran , 2017 .

[2]  M. Noroozi,et al.  The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran. , 2016, The International journal on drug policy.

[3]  M. Noroozi,et al.  Client-Level Coverage of Needle and Syringe Program and High-Risk Injection Behaviors: A Case Study of People Who Inject Drugs in Kermanshah, Iran , 2015, Addiction & health.

[4]  J. Pope,et al.  Extending coarsened exact matching to multiple cohorts: an application to longitudinal well-being program evaluation within an employer population , 2015, Health Services and Outcomes Research Methodology.

[5]  Hongyun Fu,et al.  Do community-based strategies reduce HIV risk among people who inject drugs in China? A quasi-experimental study in Yunnan and Guangxi provinces , 2014, Harm Reduction Journal.

[6]  R. Bluthenthal,et al.  Characteristics of people who initiate injection drug use later in life. , 2014, Drug and alcohol dependence.

[7]  M. Abrahamowicz,et al.  Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  M. Hellard,et al.  Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study. , 2014, The International journal on drug policy.

[9]  Michael W. Spiller,et al.  Prevalence of HIV Infection and Risk Behaviors Among Younger and Older Injecting Drug Users in the United States, 2009 , 2014, AIDS and Behavior.

[10]  S. Lenton,et al.  The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs. , 2013, Drug and alcohol dependence.

[11]  A. Haghdoost,et al.  HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey , 2013, Sexually Transmitted Infections.

[12]  M. Brandeau,et al.  Cost Effectiveness of Screening Strategies for Early Identification of HIV and HCV Infection in Injection Drug Users , 2012, PloS one.

[13]  A. Haghdoost,et al.  Modeling of human immunodeficiency virus modes of transmission in Iran. , 2012, Journal of research in health sciences.

[14]  A. Rahimi-Movaghar,et al.  HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007. , 2012, The International journal on drug policy.

[15]  R. Majdzadeh,et al.  What are Differences between Non-injecting and Injecting Drug Addicts? , 2012, International journal of preventive medicine.

[16]  A. Mirzazadeh,et al.  Modelling of HIV / AIDS in Iran up to 2014 , 2012 .

[17]  M. Schechter,et al.  The Cedar Project: risk factors for transition to injection drug use among young, urban Aboriginal people , 2011, Canadian Medical Association Journal.

[18]  Elizabeth A Stuart,et al.  Matching methods for causal inference: A review and a look forward. , 2010, Statistical science : a review journal of the Institute of Mathematical Statistics.

[19]  E. Vittinghoff,et al.  Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco. , 2009, Drug and alcohol dependence.

[20]  M. Forouzanfar,et al.  Prevalence of HIV and Hepatitis C Virus Infections and Related Behavioral Determinants among Injecting Drug Users of Drop-in Centers in Iran , 2009 .

[21]  M Mofizul Islam,et al.  The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings. , 2008, The International journal on drug policy.

[22]  Linda Richter,et al.  Behavioural strategies to reduce HIV transmission: how to make them work better , 2008, The Lancet.

[23]  B. Eshrati,et al.  Preventing HIV transmission among Iranian prisoners: Initial support for providing education on the benefits of harm reduction practices , 2008, Harm reduction journal.

[24]  C. Watts,et al.  A systematic review of published evidence on intervention impact on condom use in sub-Saharan Africa and Asia , 2007, Sexually Transmitted Infections.

[25]  C. Watts,et al.  Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India , 2007, BMC Public Health.

[26]  H. Klee,et al.  Hepatitis C testing and injecting risk behaviour: the results of a UK based pilot study , 2004 .

[27]  J. Coste,et al.  HCV status knowledge and risk behaviours amongst intravenous drug users , 2000, European Journal of Epidemiology.

[28]  D. Vlahov,et al.  Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  N. Crofts,et al.  Peer-delivered hepatitis C testing and counselling: a means of improving the health of injecting drug users. , 2002, Drug and alcohol review.

[30]  M. Mccusker Influence of hepatitis C status on alcohol consumption in opiate users in treatment. , 2001, Addiction.